CompletedPhase 2NCT03693781

Colchicine for Amyotrophic Lateral Sclerosis

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Azienda Ospedaliero-Universitaria di Modena
Principal Investigator
Jessica Mandrioli
Azienda Ospedaliero-Universitaria di Modena
Intervention
Colchicine 1 MG Oral Tablet(drug)
Enrollment
54 enrolled
Eligibility
18-80 years · All sexes
Timeline
20192023

Study locations (8)

Collaborators

University of Modena and Reggio Emilia · University of Turin, Italy · Istituto Auxologico Italiano · IRCCS National Neurological Institute "C. Mondino" Foundation · University of Bari · IRCCS San Raffaele · University of Padova · University of Milan · Istituto Di Ricerche Farmacologiche Mario Negri · University of Campania Luigi Vanvitelli · Catholic University of the Sacred Heart

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03693781 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis

← Back to all trials